Consilio Wealth Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$695K Sell
2,737
-49
-2% -$11.4K 0.17% 45
2026
Q1
$681K Buy
2,786
+63
+2% +$14.7K 0.2% 43
2025
Q4
$564K Buy
2,723
+51
+2% +$10.1K 0.16% 46
2025
Q3
$496K Buy
2,672
+382
+17% +$65.4K 0.16% 45
2025
Q2
$349K Sell
2,290
-185
-7% -$28.4K 0.12% 47
2025
Q1
$411K Buy
2,475
+455
+23% +$71.2K 0.17% 42
2024
Q4
$292K Sell
2,020
-60
-3% -$9.3K 0.12% 49
2024
Q3
$337K Buy
2,080
+698
+51% +$111K 0.14% 46
2024
Q2
$202K Sell
1,382
-503
-27% -$74.8K 0.09% 63
2024
Q1
$298K Buy
1,885
+100
+6% +$15.9K 0.14% 45
2023
Q4
$280K Buy
1,785
+357
+25% +$54.7K 0.14% 44
2023
Q3
$222K Buy
1,428
+198
+16% +$32.7K 0.13% 47
2023
Q2
$204K Buy
+1,230
New +$199K 0.11% 49
2023
Q1
Sell
-1,184
Closed -$209K 47
2022
Q4
$209K Buy
+1,184
New +$204K 0.13% 46

Other funds holding JNJ

Consilio Wealth Advisors's JNJ Position: Q2 2026 in Review

Consilio Wealth Advisors reduced its Johnson & Johnson (JNJ) stake by 1.8% in Q2 2026, selling an estimated $11.4K and leaving 2,737 shares worth $695K. The position accounts for 0.17% of the portfolio, ranked #45.

Consilio Wealth Advisors first reported a position in JNJ in Q4 2022 and has held it in 14 quarters since. 4,656 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Consilio Wealth Advisors held 2,737 shares of Johnson & Johnson worth $695K as of Q2 2026.
  • Consilio Wealth Advisors sold 49 Johnson & Johnson shares in Q2 2026, an estimated $11.4K.
  • Johnson & Johnson made up 0.17% of Consilio Wealth Advisors's portfolio in Q2 2026, its #45 holding.
  • Consilio Wealth Advisors first reported a position in Johnson & Johnson in Q4 2022 and has held it in 14 quarters since.
  • 4,656 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Consilio Wealth Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.